Skip to main content
. 2015 Apr 27;10(4):e0117125. doi: 10.1371/journal.pone.0117125

Fig 1. Preclinical markers of atherosclerosis are elevated in EFV-treated and LPV/r-treated subjects compared to HAART-naïve and NVP-treated.

Fig 1

Wilcoxon rank sum test p-values are shown. *Note: Although the pairwise Wilcoxon rank sum test showed differences in cIMT between EFV- and LPV/r-treated and NVP-treated subject, ANOVA yielded a p = 0.12, which is above the defined criteria of p<0.05 for statistical significance. When normalized to carotid artery diameter (cIMT-norm = cIMT/(D/2), where D = carotid diameter), EFV- and LPV/r-treated subjects exhibited significantly increased values compared to NVP-treated and HAART-naïve subject.